We can make predictions about financing and dilution. If we observe the trend of the past four financing deals, it is clear that they become notably less favorable each time. It is clear IPX has exhausted reasonable sources of capital and needs a partnership to turn it around.
Even if IPIX could sell at the market price of $0.13 with no discount, no warrant, and no disruption to the stock price, $1M = 7.6M shares. Those same 7.6M shares would have netted $20M-30M back in 2015.
It's deal time and soon.
(2)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links